Skip to main content
Patient stories. Al, real Scemblix patient. Al was compensated for his time.

Hear from other adult patients with
Ph+ CML in chronic phase

You don’t have to go through this alone. People living with Ph+ CML in chronic phase (Ph+ CML-CP) can find their community, whether it is online or in person. 

Hear from Kat and Al who have CML in real life (IRL).

Meet Kat

Kat was diagnosed with CML when she was just 19 years old.

Meet Al

In 1997, Al was diagnosed with CML. He struggled with unmanageable side effects from a treatment that wasn’t a good fit.

Ph+ CML-CP, Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase.

*SCEMBLIX was studied vs GLEEVEC® (imatinib), TASIGNA® (nilotinib), Sprycel ® (dasatinib), and Bosulif ® (bosutinib). Sprycel is a registered trademark of Bristol-Myers Squibb Company. Bosulif is a registered trademark of Pfizer Inc.